Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Risk of red cell exposure to the water anomaly upon blood unit cold-storage.

Arbell D, Gertzulin M, Zelig O, Wexler TLR, Barshtein G, Yedgar S.

Am J Hematol. 2018 Dec;93(12):E397-E398. doi: 10.1002/ajh.25280. Epub 2018 Oct 9. No abstract available.

PMID:
30203505
2.

Hemodynamic Functionality of Transfused Red Blood Cells in the Microcirculation of Blood Recipients.

Barshtein G, Arbell D, Yedgar S.

Front Physiol. 2018 Jan 30;9:41. doi: 10.3389/fphys.2018.00041. eCollection 2018. Review.

3.

Biophysical and Biochemical Markers of Red Blood Cell Fragility.

Orbach A, Zelig O, Yedgar S, Barshtein G.

Transfus Med Hemother. 2017 Jun;44(3):183-187. doi: 10.1159/000452106. Epub 2017 Apr 4.

4.

Deformability of transfused red blood cells is a potent effector of transfusion-induced hemoglobin increment: A study with β-thalassemia major patients.

Barshtein G, Goldschmidt N, Pries AR, Zelig O, Arbell D, Yedgar S.

Am J Hematol. 2017 Sep;92(9):E559-E560. doi: 10.1002/ajh.24821. Epub 2017 Jul 19. No abstract available.

5.

The dielectric spectroscopy of human red blood cells: the differentiation of old from fresh cells.

David M, Levy E, Feldman Y, Ben Ishai P, Zelig O, Yedgar S, Barshtein G.

Physiol Meas. 2017 Jun 22;38(7):1335-1348. doi: 10.1088/1361-6579/aa707a.

PMID:
28462905
6.

Dielectric Response of Cytoplasmic Water and Its Connection to the Vitality of Human Red Blood Cells. II. The Influence of Storage.

Levy E, David M, Barshtein G, Yedgar S, Livshits L, Ben Ishai P, Feldman Y.

J Phys Chem B. 2017 May 25;121(20):5273-5278. doi: 10.1021/acs.jpcb.7b02662. Epub 2017 May 11.

PMID:
28453275
7.

Phospholipase D messenger RNA expression and clinical role in high-grade serous carcinoma.

Harel-Dassa K, Yedgar S, Tropé CG, Davidson B, Reich R.

Hum Pathol. 2017 Apr;62:115-121. doi: 10.1016/j.humpath.2016.12.023. Epub 2017 Jan 11.

PMID:
28087476
8.

Erythrocyte survival is controlled by microRNA-142.

Rivkin N, Chapnik E, Mildner A, Barshtein G, Porat Z, Kartvelishvily E, Dadosh T, Birger Y, Amir G, Yedgar S, Izraeli S, Jung S, Hornstein E.

Haematologica. 2017 Apr;102(4):676-685. doi: 10.3324/haematol.2016.156109. Epub 2016 Dec 1.

9.

Deformability of transfused red blood cells is a potent determinant of transfusion-induced change in recipient's blood flow.

Barshtein G, Pries AR, Goldschmidt N, Zukerman A, Orbach A, Zelig O, Arbell D, Yedgar S.

Microcirculation. 2016 Oct;23(7):479-486. doi: 10.1111/micc.12296.

PMID:
27406436
10.

Polystyrene Nanoparticles Activate Erythrocyte Aggregation and Adhesion to Endothelial Cells.

Barshtein G, Livshits L, Shvartsman LD, Shlomai NO, Yedgar S, Arbell D.

Cell Biochem Biophys. 2016 Mar;74(1):19-27. doi: 10.1007/s12013-015-0705-6.

PMID:
26972298
11.

Phospholipase A2-dependent release of inflammatory cytokines by superantigen-stimulated nasal polyps of patients with chronic rhinosinusitis.

Mruwat R, Kivity S, Landsberg R, Yedgar S, Langier S.

Am J Rhinol Allergy. 2015 Sep-Oct;29(5):e122-8. doi: 10.2500/ajra.2015.29.4224.

PMID:
26358335
12.

Diabetic foot disease is associated with reduced erythrocyte deformability.

Cahn A, Livshits L, Srulevich A, Raz I, Yedgar S, Barshtein G.

Int Wound J. 2016 Aug;13(4):500-4. doi: 10.1111/iwj.12466. Epub 2015 May 28.

PMID:
26018868
13.

Storage-induced damage to red blood cell mechanical properties can be only partially reversed by rejuvenation.

Barshtein G, Gural A, Manny N, Zelig O, Yedgar S, Arbell D.

Transfus Med Hemother. 2014 Jun;41(3):197-204. doi: 10.1159/000357986. Epub 2014 Apr 14.

14.

Phospholipase A2 in experimental allergic bronchitis: a lesson from mouse and rat models.

Mruwat R, Yedgar S, Lavon I, Ariel A, Krimsky M, Shoseyov D.

PLoS One. 2013 Oct 29;8(10):e76641. doi: 10.1371/journal.pone.0076641. eCollection 2013.

15.

Phospholipase A(2) inhibition as potential therapy for inflammatory skin diseases.

Mruwat R, Cohen Y, Yedgar S.

Immunotherapy. 2013 Apr;5(4):315-7. doi: 10.2217/imt.13.18. Review. No abstract available.

16.

Effect of short-term hyperglycemia on protein kinase C alpha activation in human erythrocytes.

Livshits L, Srulevich A, Raz I, Cahn A, Barshtein G, Yedgar S, Eldor R.

Rev Diabet Stud. 2012 Summer-Fall;9(2-3):94-103. doi: 10.1900/RDS.2012.9.94. Epub 2012 Nov 15.

17.

Resuscitation with aged blood exacerbates liver injury in a hemorrhagic rat model.

Matot I, Katz M, Pappo O, Zelig O, Corchia N, Yedgar S, Barshtein G, Bennett-Guerrero E, Abramovitch R.

Crit Care Med. 2013 Mar;41(3):842-9. doi: 10.1097/CCM.0b013e3182711b38. Erratum in: Crit Care Med. 2013 Apr;41(4):e41. Guerrero, Elliot Bennett [corrected to Bennett-Guerrero, Elliot].

PMID:
23314580
18.

Phospholipase A₂ activities in skin physiology and pathology.

Dan P, Rosenblat G, Yedgar S.

Eur J Pharmacol. 2012 Sep 15;691(1-3):1-8. doi: 10.1016/j.ejphar.2012.07.023. Epub 2012 Jul 20. Review.

PMID:
22819703
19.

Hemolytic effect of polymeric nanoparticles: role of albumin.

Barshtein G, Arbell D, Yedgar S.

IEEE Trans Nanobioscience. 2011 Dec;10(4):259-61. doi: 10.1109/TNB.2011.2175745. Epub 2011 Nov 22.

PMID:
22128012
20.

Attenuation of experimental TPA-induced dermatitis by acetylenic acetogenins is associated with inhibition of PLA₂ activity.

Otuki MF, Schwob O, Silveira Prudente A, Zaltsman I, Meretski S, Segal J, Yedgar S, Rosenblat G.

Eur J Pharmacol. 2011 Dec 15;672(1-3):175-9. doi: 10.1016/j.ejphar.2011.09.184. Epub 2011 Oct 2.

PMID:
22001563
21.

Erythrocyte aggregation as a cause of slow flow in patients of acute coronary syndromes.

Arbel Y, Banai S, Benhorin J, Finkelstein A, Herz I, Halkin A, Keren G, Yedgar S, Barashtein G, Berliner S.

Int J Cardiol. 2012 Feb 9;154(3):322-7. doi: 10.1016/j.ijcard.2011.06.116. Epub 2011 Jul 23.

PMID:
21783264
22.

Circulatory risk in the transfusion of red blood cells with impaired flow properties induced by storage.

Barshtein G, Manny N, Yedgar S.

Transfus Med Rev. 2011 Jan;25(1):24-35. doi: 10.1016/j.tmrv.2010.08.004. Review.

PMID:
21134624
23.

Plasma factor in red blood cells adhesion to endothelial cells: humans and rats.

Schlager A, Zamir G, Barshtein G, Yedgar S, Arbell D.

Cell Biochem Biophys. 2010 Dec;58(3):157-61. doi: 10.1007/s12013-010-9102-3.

PMID:
20725802
24.

Vitamin E induces phosphatidylserine externalization and red cell adhesion to endothelial cells.

Koshkaryev A, Barshtein G, Yedgar S.

Cell Biochem Biophys. 2010 Apr;56(2-3):109-14. doi: 10.1007/s12013-009-9074-3.

PMID:
20020330
25.

Rejuvenation treatment of stored red blood cells reverses storage-induced adhesion to vascular endothelial cells.

Koshkaryev A, Zelig O, Manny N, Yedgar S, Barshtein G.

Transfusion. 2009 Oct;49(10):2136-43. doi: 10.1111/j.1537-2995.2009.02251.x. Epub 2009 Jun 15.

PMID:
19538542
26.

Increased strength of erythrocyte aggregates in blood of patients with inflammatory bowel disease.

Maharshak N, Arbel Y, Shapira I, Berliner S, Ben-Ami R, Yedgar S, Barshtein G, Dotan I.

Inflamm Bowel Dis. 2009 May;15(5):707-13. doi: 10.1002/ibd.20838.

PMID:
19137610
27.

Increased red blood cell aggregation in patients with Gaucher disease is non-inflammatory.

Adar T, Ben-Ami R, Elstein D, Zimran P, Berliner S, Yedgar S, Barshtein G.

Clin Hemorheol Microcirc. 2008;40(2):113-8.

PMID:
19029636
28.

Additive effect of red blood cell rigidity and adherence to endothelial cells in inducing vascular resistance.

Kaul DK, Koshkaryev A, Artmann G, Barshtein G, Yedgar S.

Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1788-93. doi: 10.1152/ajpheart.253.2008. Epub 2008 Aug 29.

29.

RBC adhesion to vascular endothelial cells: more potent than RBC aggregation in inducing circulatory disorders.

Yedgar S, Kaul DK, Barshtein G.

Microcirculation. 2008 Oct;15(7):581-3. doi: 10.1080/10739680802105482. Review.

PMID:
18720230
30.

Premature red blood cells have decreased aggregation and enhanced aggregability.

Arbell D, Orkin B, Bar-Oz B, Barshtein G, Yedgar S.

J Physiol Sci. 2008 Jun;58(3):161-5. doi: 10.2170/physiolsci.RP004408. Epub 2008 Apr 15.

PMID:
18405459
31.

Activation of cytosolic phospholipase A2 and fatty acid transacylase is essential but not sufficient for thrombin-induced smooth muscle cell proliferation.

Gluck N, Schwob O, Krimsky M, Yedgar S.

Am J Physiol Cell Physiol. 2008 Jun;294(6):C1597-603. doi: 10.1152/ajpcell.00206.2007. Epub 2008 Apr 2.

32.

Phenylhydrazine as a partial model for beta-thalassaemia red blood cell hemodynamic properties.

Ramot Y, Koshkaryev A, Goldfarb A, Yedgar S, Barshtein G.

Br J Haematol. 2008 Mar;140(6):692-700. doi: 10.1111/j.1365-2141.2007.06976.x.

PMID:
18302715
33.
34.

Blood banking-induced alteration of red blood cell flow properties.

Relevy H, Koshkaryev A, Manny N, Yedgar S, Barshtein G.

Transfusion. 2008 Jan;48(1):136-46. Epub 2007 Sep 27.

PMID:
17900281
35.

Treatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword?

Yedgar S, Krimsky M, Cohen Y, Flower RJ.

Trends Pharmacol Sci. 2007 Sep;28(9):459-64. Epub 2007 Aug 10. Review.

PMID:
17692394
36.

Role of red blood cell flow behavior in hemodynamics and hemostasis.

Barshtein G, Ben-Ami R, Yedgar S.

Expert Rev Cardiovasc Ther. 2007 Jul;5(4):743-52. Review.

PMID:
17605652
37.

A novel treatment of contact dermatitis by topical application of phospholipase A2 inhibitor: a double-blind placebo-controlled pilot study.

Ingber A, Cohen Y, Krimsky M, Yedgar S.

Int J Immunopathol Pharmacol. 2007 Jan-Mar;20(1):191-5.

PMID:
17346444
38.

Control of phospholipase A2 activities for the treatment of inflammatory conditions.

Yedgar S, Cohen Y, Shoseyov D.

Biochim Biophys Acta. 2006 Nov;1761(11):1373-82. Epub 2006 Aug 3. Review.

PMID:
16978919
39.

Aggregation of red blood cells in patients with Gaucher disease.

Adar T, Ben-Ami R, Elstein D, Zimran A, Berliner S, Yedgar S, Barshtein G.

Br J Haematol. 2006 Aug;134(4):432-7. Epub 2006 Jul 10.

PMID:
16827817
40.

Plasma dependent reduction in red blood cell aggregation after dextran sulfate low-density lipoprotein apheresis--implications for rheological studies.

Schechner V, Ben-Ami R, Hershcovici T, Yedgar S, Beigel Y, Shapira I, Berliner S, Barsthein G.

Ther Apher Dial. 2005 Oct;9(5):379-84.

PMID:
16202011
41.

Treatment of ovalbumin-induced experimental allergic bronchitis in rats by inhaled inhibitor of secretory phospholipase A(2).

Shoseyov D, Bibi H, Offer S, Schwob O, Krimsky M, Kleiman M, Yedgar S.

Thorax. 2005 Sep;60(9):747-53. Epub 2005 Jun 30.

42.

Aggregability of red blood cells of schizophrenia patients with negative syndrome is selectively enhanced.

Barshtein G, Ponizovsky AM, Nechamkin Y, Ritsner M, Yedgar S, Bergelson LD.

Schizophr Bull. 2004;30(4):913-22.

PMID:
15954197
43.

Disseminated thrombosis-induced growth plate necrosis in rat: a unique model for growth plate arrest.

Nyska M, Shabat S, Long PH, Howard C, Ezov N, Levin-Harrus T, Mittelman M, Redlich M, Yedgar S, Nyska A.

J Pediatr Orthop. 2005 May-Jun;25(3):346-50.

PMID:
15832152
44.

Negative feedback between secretory and cytosolic phospholipase A2 and their opposing roles in ovalbumin-induced bronchoconstriction in rats.

Offer S, Yedgar S, Schwob O, Krimsky M, Bibi H, Eliraz A, Madar Z, Shoseyov D.

Am J Physiol Lung Cell Mol Physiol. 2005 Mar;288(3):L523-9. Epub 2004 Nov 19.

45.

Flow-resistant red blood cell aggregation in morbid obesity.

Samocha-Bonet D, Ben-Ami R, Shapira I, Shenkerman G, Abu-Abeid S, Stern N, Mardi T, Tulchinski T, Deutsch V, Yedgar S, Barshtein G, Berliner S.

Int J Obes Relat Metab Disord. 2004 Dec;28(12):1528-34.

PMID:
15467777
46.

The degree of red blood cell aggregation on peripheral blood glass slides corresponds to inter-erythrocyte cohesive forces in laminar flow.

Berliner S, Ben-Ami R, Samocha-Bonet D, Abu-Abeid S, Schechner V, Beigel Y, Shapira I, Yedgar S, Barshtein G.

Thromb Res. 2004;114(1):37-44.

PMID:
15262483
47.

Control of angiogenesis by inhibitor of phospholipase A2.

Chen W, Li L, Zhu J, Liu J, Soria J, Soria C, Yedgar S.

Chin Med Sci J. 2004 Mar;19(1):6-12.

PMID:
15104217
48.

Protection against Chlamydia trachomatis infection in vitro and modulation of inflammatory response in vivo by membrane-bound glycosaminoglycans.

Darville T, Yedgar S, Krimsky M, Andrews CW Jr, Jungas T, Ojcius DM.

Microbes Infect. 2004 Apr;6(4):369-76.

PMID:
15050964
49.

Ocular expression of vascular cell adhesion molecule (VCAM-1) in 2-butoxyethanol-induced hemolysis and thrombosis in female rats.

Nyska A, Moomaw CR, Ezov N, Shabat S, Levin-Harrus T, Nyska M, Redlich M, Mittelman M, Yedgar S, Foley JF.

Exp Toxicol Pathol. 2003 Nov;55(4):231-6.

PMID:
14703767
50.

Extracellular phospholipase A2 inhibitors suppress central nervous system inflammation.

Pinto F, Brenner T, Dan P, Krimsky M, Yedgar S.

Glia. 2003 Dec;44(3):275-82.

PMID:
14603468

Supplemental Content

Loading ...
Support Center